Focus on sticking to the peak forever -- the enlightenment of Jianfeng Group's 60 years of entrepreneurship
Release time:
2020-07-31
Editor's Note: 11# March 20 , Jinhua Daily 1 edition published "Focus on Climbing the Peak Eternal-Enlightenment of Jianfeng Group's Entrepreneurship 60 " written by the reporter of the newspaper, which is specially reprinted by this newspaper.
Focus on Climbing to the Peak for All Times
-Enlightenment of Jianfeng Group's Entrepreneurship 60
Jinhua Daily Reporter Shao Xuilian
As of the end of the third quarter of this year, total assets 47.88 .5 billion yuan, net assets 33.66 .7 billion yuan, and net profit attributable to the parent company reached 4.88 .9 billion yuan, earnings per share 1.42 yuan. Recently, Jianfeng Group disclosed its beautiful third quarter report of 2018 , celebrating the 35th anniversary of its venture 60 with its best operating results in history.
60 years. With sustained and steady high-quality development, the peak people are moving towards a comprehensive modern enterprise group with strong core competitiveness.
, the first generation of peak people built the first cement factory in Jinhua history at the foot of peak mountain. 1983# Beginning in , through horizontal alliances with township enterprises, the formation of enterprise groups, and the implementation of shareholding reforms, Peak developed from a small state-owned cement plant to the first listed company in China's cement industry. Since then, in the stage of diversification, the peak will develop the pharmaceutical industry into the second pillar industry. 2007 , with the central enterprise China Building Materials, to participate in the formation of Southern Cement, the cement industry focus of strategic transfer; at the same time, through mergers and acquisitions, scientific and technological innovation, the pharmaceutical industry to further develop.
33 participating and holding subsidiaries, involving six major industries of building materials, medicine, health, modern logistics, international trade and communication cables. It is the earliest existing A listed company in our province. On the 63rd anniversary of
25#, Chairman Jiang Xiaomeng said that Jianfeng Group's continued stability benefits from its long-term strategic positioning of focusing on industry, which is the value orientation of Jianfeng and the responsibility of the enterprise. At the same time, it benefits from the combination of cyclical and non-cyclical dual-main business operating structure, and benefits from the core competitiveness formed in the long-term market competition. Cement is the foundation of the enterprise. Peak timely transfers the strategic focus of the cement industry to the areas along the national "the belt and road initiative", strengthens intelligent management and green production, and ensures excellent quality and profitability. As one of the "Top 50 Cement in China" and one of the
large enterprises with the state's key support for the structural adjustment of the cement industry, Spike Cement has established its position as a cost leader in the regional market, especially by virtue of its profitability per ton of cement, which ranks among the top in the industry. In the pharmaceutical sector, Jianfeng Group, on the one hand, has increased industrial mergers and acquisitions and improved the industrial chain. At present, Jianfeng Pharmaceutical has owned
wholly-owned, holding and participating pharmaceutical research and development and production enterprises. There are 3 pharmaceutical trading enterprises, which have established the production system of three major production bases of pharmaceutical intermediate raw materials, proprietary Chinese medicine preparations and chemical medicine preparations. On the other hand, intensify the development of new products, and form a research and development system with 1 provincial drug research institutes, 3 academician expert workstations, 4 postdoctoral workstations as the leading research and development institutions and four innovative drug development subjects. At present, it has 52 international and domestic patents, including 43 invention patents, ranking the top three in the market share of leading products, and increasing the research and development of anti-tumor drugs and infant drugs to become a technology leader in subdivided fields. Pattern: Open and Inclusive
The strategic transfer of cement industry is cooperation and integration. The sudden rise of the pharmaceutical industry is also inseparable from cooperation and integration. For the "old enterprise" of Jianfeng Group, the partners feel the same: the pattern is very large. In 2007
Kang Litao, general manager of Shanghai North Carolina Pharmaceutical, said that after joining Jianfeng Group, he deeply felt that although this is an old listed company restructured by a state-owned enterprise, the degree of standardization, marketization, and modernization is very high. The position of the helmsman is high, especially the high-tech talents are highly respected.
# Wang Yiyan, deputy manager of 104 daye peak manufacturing department, is a local and entered the enterprise in 2007
years in a row. Although some people often want to pay them a high salary, they all say with one voice: "I just want to be a peak worker." , as a high-tech peak pharmaceutical sector, has gathered a group of high-tech talents. The peak meets the needs of talents to "build a nest and attract the phoenix". Where the talents are, the R & D institutions will be established. It has attracted a large number of industry leaders and "returnees" talents, and promoted the innovation and development of new products and drugs.
Some people say that corporate culture is the boss culture. Jiang Xiaomeng started as a worker in Jianfeng Group, but he is also a recognized expert entrepreneur; as the chairman of a listed company, he is observing the general trend and seeking great things, but he has no airs in front of the employees, long-distance business trips, and the driver is tired on the way., He will drive by himself and let the driver take a rest in the passenger seat. He once said that the invisible road lies in seizing the opportunity. The impermanent law lies in taking advantage of the situation. Great skill selflessness lies in uniting people's hearts.
60 is a group of peak people with similar values and a unique peak culture leading the growth of the workforce. Over the years, Jianfeng Group has continuously integrated resources and added more and more new employees. Next, in the face of the complicated economic situation and fully competitive industry pattern, the adjustment of industrial structure will be increased, the integration and improvement of M & A enterprises need to be accelerated, and the training and upgrading of talents will be accelerated. It is necessary to require the peak to be in addition to the values of "being brave to open up, keeping pace with the times, and climbing the peak forever, integrate into the corporate culture of" innovation, tolerance, honesty and responsibility.
Management: Standardization and Science
If "Cooperation and Innovation to Strengthen the Main Business" emphasizes openness and inclusiveness, "Standardization and Science for Development" emphasizes management.
OA management system, financial management system, human resource management system, video conference system, etc. covering all enterprises of the group company, it realizes convenient management of cross-regional development while improving daily work efficiency. In addition, we will continue to carry out fine management. Through
on-site management of lean production, benchmarking management and comprehensive budget management, we will institutionalize and proceduralize them and become the daily management procedures and work habits of employees. Establish an assessment and evaluation system for managers at all levels, use the evaluation system to stimulate the motivation of managers, restrict the behavior of managers, and continue to promote the development of enterprise management to a high level and high efficiency. In order to promote the optimization of enterprise organization and post optimization, Jianfeng Group introduced the "amoeba" management concept in 2016
However, Jiang Xiaomeng said that as an enterprise manager, one must have a clear mind. Today's success does not mean eternal success in the future. Past glory does not mean eternal glory in the future. The management of a successful enterprise is always on the road. "We still have a lot to improve, improve and reform. For example, we still have a gap with advanced companies in terms of the quality and speed of innovative research and development, and we still have a lot to do in terms of lean production, technological innovation, cost control and seeking connotative growth." He said, "In the future, while doing a good business, we will pay more attention to social responsibility. Our goal is to be a century-old enterprise, a respected enterprise, so we will never be satisfied."
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page